AU2206701A - A reversible linkage technology for controlled conjugation - Google Patents
A reversible linkage technology for controlled conjugationInfo
- Publication number
- AU2206701A AU2206701A AU22067/01A AU2206701A AU2206701A AU 2206701 A AU2206701 A AU 2206701A AU 22067/01 A AU22067/01 A AU 22067/01A AU 2206701 A AU2206701 A AU 2206701A AU 2206701 A AU2206701 A AU 2206701A
- Authority
- AU
- Australia
- Prior art keywords
- reversible linkage
- linkage technology
- controlled conjugation
- conjugation
- controlled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9930233.3A GB9930233D0 (en) | 1999-12-21 | 1999-12-21 | A reversible linkage technology for controlled conjugation |
| GB9930233 | 1999-12-21 | ||
| GB0004096 | 2000-02-22 | ||
| GB0004096A GB0004096D0 (en) | 2000-02-22 | 2000-02-22 | A reversible linkage technology for controlled conjugation |
| GB0020708A GB0020708D0 (en) | 2000-08-22 | 2000-08-22 | A reversible linkage technology for controlled conjugation |
| GB0020707 | 2000-08-22 | ||
| GB0020707A GB0020707D0 (en) | 2000-08-22 | 2000-08-22 | A reversible linkage technology for controlled conjugation |
| GB0020708 | 2000-08-22 | ||
| PCT/GB2000/004935 WO2001045745A2 (en) | 1999-12-21 | 2000-12-21 | A reversible linkage technology for controlled conjugation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2206701A true AU2206701A (en) | 2001-07-03 |
Family
ID=27447796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU22067/01A Abandoned AU2206701A (en) | 1999-12-21 | 2000-12-21 | A reversible linkage technology for controlled conjugation |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2206701A (en) |
| WO (1) | WO2001045745A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050007454A (en) * | 2002-04-08 | 2005-01-18 | 아무라 테라피틱스 리미티드 | Organic molecules |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4033714C3 (en) * | 1990-10-24 | 1995-09-07 | Brahms Diagnostica Gmbh | New hapten analysis based on the principle of an antigen-antibody reaction |
| JPH072895A (en) * | 1993-04-28 | 1995-01-06 | Eli Lilly & Co | Antibody - drug conjugate |
| US6001364A (en) * | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
| WO1995003321A1 (en) * | 1993-07-20 | 1995-02-02 | Bionebraska, Inc. | Method for endomodification of proteins |
| WO1997024459A1 (en) * | 1995-12-29 | 1997-07-10 | Phanos Technologoes, Inc. | Method for reducing unwanted cellular adhesions |
| GB9621985D0 (en) * | 1996-10-22 | 1996-12-18 | Peptide Therapeutics Ltd | A solid-phase technology for the preparation of libraries of bi-directally functionalised drug-like molecules |
| IL145025A0 (en) * | 1999-02-25 | 2002-06-30 | Smithkline Beecham Biolog | Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses |
-
2000
- 2000-12-21 AU AU22067/01A patent/AU2206701A/en not_active Abandoned
- 2000-12-21 WO PCT/GB2000/004935 patent/WO2001045745A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001045745A3 (en) | 2002-05-10 |
| WO2001045745A2 (en) | 2001-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPQ339099A0 (en) | A humidifier | |
| AU1228001A (en) | Adjustable linkage for a watchband | |
| AU2467600A (en) | Compact actuator | |
| AU4161800A (en) | A beam connection | |
| AU8018200A (en) | A knowledge-engineering protocol-suite | |
| AUPP923099A0 (en) | A ball | |
| AU6183700A (en) | Erythromycin a derivatives | |
| AU5093700A (en) | Actuator | |
| AU2567701A (en) | Written command | |
| AU4031000A (en) | Wavelength compensation in a wsxc using off-voltage control | |
| AU2206701A (en) | A reversible linkage technology for controlled conjugation | |
| AU4308001A (en) | Transition metal-cyclopentadienyl-tropane conjugates | |
| AU6316400A (en) | Erythromycin a derivatives | |
| AU6183800A (en) | Erythromycin a derivatives | |
| AU6748400A (en) | A single-compiler architecture | |
| GB9930233D0 (en) | A reversible linkage technology for controlled conjugation | |
| WO2000070484A8 (en) | A market operating system | |
| GB0020707D0 (en) | A reversible linkage technology for controlled conjugation | |
| GB0004096D0 (en) | A reversible linkage technology for controlled conjugation | |
| GB0020708D0 (en) | A reversible linkage technology for controlled conjugation | |
| AU1544100A (en) | Bale bagger | |
| AU1520601A (en) | Antifungal sordaricin derivatives | |
| AU5998700A (en) | A three demensional figure | |
| AUPQ275999A0 (en) | Implement linkage | |
| AUPQ449699A0 (en) | A mechanism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |